Copyright
©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 429-441
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.429
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.429
Figure 1 The statistical analysis subsequently focused on β-Arr-2 expression in the gastric antrum.
Cytoplasmic staining of β-Arrestin-2 (× 40) showing (A, B, C) low, moderate, and strong expression in the gastric antrum; (D, E) moderate and strong expression in the gastric body; and (F) strong expression in the duodenum respectively.
- Citation: Lashen SA, Shamseya MM, Madkour MA, Abdel Salam RM, Mostafa SS. β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study. World J Hepatol 2022; 14(2): 429-441
- URL: https://www.wjgnet.com/1948-5182/full/v14/i2/429.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i2.429